Sommaire

Numéro précédent | Numéro suivant

• • ·Co-infection: new battlegrounds in HIV/AIDS

    Page :559

     
• • ·Economics of monitoring antiretroviral therapy

    Page :560-561

    Jonathan Mermin, Reuben Granich

     
• • ·A benchmark for management of drug resistant HIV

    Page :561-562

    Anton L Pozniak, Jose R Arribas

    
• • ·Boceprevir for HCV in patients with HIV: where next?

    Page :563-564

    Anuoluwapo Osinusi, Susanna Naggie

      
• • ·Inoculating communities against vaccine scare stories

    Page :564-565

    Natasha Sarah Crowcroft, Kwame Julius McKenzie

    
• • ·Panton-Valentine leucocidin and pneumonia

    Page :566

    Binh An Diep, Yves Gillet, Jerome Etienne, Gerard Lina, François Vandenesch

    
• • ·Panton-Valentine leucocidin and pneumonia – Authors’ reply

    Page :566-567

    Laura J Shallcross, Andrew C Hayward

    
• • ·Behavioural research in epidemics

    Page :567

    Qiuyan Liao, Richard Fielding

    
• • ·Behavioural research in epidemics

    Page :567-568

    Laëtitia Atlani-Duault, Cécile Rousseau, Jean-Paul Moatti, Jean-François Delfraissy, Bernadette Murgue

    
• • ·Behavioural research in epidemics – Authors’ reply

    Page :568

    Gillian K SteelFisher, Robert J Blendon

    
• • ·Rifampicin and moxifloxacin for tuberculous meningitis

    Page :568-569

    Onno Akkerman, Arianna Pranger, Richard van Altena, Tjip van der Werf, Jan-Willem Alffenaar

    
• • ·Rifampicin and moxifloxacin for tuberculous meningitis

    Page :569-570

    Kingsley N Ukwaja, Cajetan C Onyedum

    
• • ·Rifampicin and moxifloxacin for tuberculous meningitis – Authors’ reply

    Page :570

    Rovina Ruslami, A Rizal Ganiem, Rob E Aarnoutse, Reinout van Crevel, on behalf of the study team

    
• • ·The pros and cons of probiotics

    Page :571-572

    Carrie Arnold

     
• • ·Alarm bells over MERS coronavirus

    Page :573-574

    Neil Bennet

     
• • ·Infectious disease surveillance update

    Page :574

    Nawsheen Boodhun

    Plan Plan
• • ·Research brief

    Page :575

    Jane Bradbury

    Plan Plan  
• • ·The power of care

    Page :576

    Neil Bennet

     
• • ·Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis

    Page :577-586

    Sylvie Boyer, Laura March, Charles Kouanfack, Gabrièle Laborde-Balen, Patricia Marino, Avelin Fobang Aghokeng, Eitel Mpoudi-Ngole, Sinata Koulla-Shiro, Eric Delaporte, Maria Patrizia Carrieri, Bruno Spire, Christian Laurent, Jean-Paul Moatti, on behalf of the Stratall ANRS 12110/ESTHER Study Group, M Biwolé-Sida, C Kouanfack, S Koulla-Shiro, A Bourgeois, E Delaporte, C Laurent, M Peeters, G Laborde-Balen, M Dontsop, S Kazé, J-M Mben, A Aghokeng, M G Edoul, E Mpoudi-Ngolé, M Tongo, S Boyer, M P Carrieri, F Marcellin, J-P Moatti, B Spire, C Abé, S-C Abega, C-R Bonono, H Mimcheu, S Ngo Yebga, C Paul Bile, S Abada, T Abanda, J Baga, P Bilobi Fouda, P Etong Mve, G Fetse Tama, H Kemo, A Ongodo, V Tadewa, H D Voundi, A Ambani, M Atangana, J-C Biaback, M Kennedy, H Kibedou, F Kounga, M Maguip Abanda, E Mamang, A Mikone, S Tang, E Tchuangue, S Tchuenko, D Yakan, J Assandje, S Ebana, D Ebo'o, D Etoundi, G Ngama, P Mbarga Ango, J Mbezele, G Mbong, C Moung, N Ekotto, G Nguemba Balla, G Ottou, M Tigougmo, R Beyala, B Ebene, C Effemba, F Eyebe, M-M Hadjaratou, T Mbarga, M Metou, M Ndam, B Ngoa, E B Ngock, N Obam, A M Abomo, G Angoula, E Ekassi, J J Lentchou, I Mvilongo, J Ngapou, F Ntokombo, V Ondoua, R Palawo, S Sebe, E Sinou, D Wankam, I Zobo, B Akono, A L Ambani, L Bilock, R Bilo'o, J Boombhi, F X Fouda, M Guitonga, R Mad'aa, D R Metou'ou, S Mgbih, A Noah, M Tadena, G Ambassa Elime, A A Bonongnaba, E Foaleng, R M Heles, R Messina, O Nana Ndankou, S A Ngono, D Ngono Menounga, S S Sil, L Tchouamou, B Zambou, R Abomo, J Ambomo, C Beyomo, P Eloundou, C Ewole, J Fokom Domgue, M Mvoto, M Ngadena, R Nyolo, C Onana, A Oyie, P Antyimi, S Bella Mbatonga, M Bikomo, Y Molo Bodo, S Ndi Ntang, P Ndoudoumou, L Ndzomo, S O Ngolo, M Nkengue, Y Tchinda

    Résumé Résumé Plan Plan   
• • ·Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

    Page :587-596

    Joseph J Eron, David A Cooper, Roy T Steigbigel, Bonaventura Clotet, Jose M Gatell, Princy N Kumar, Jurgen K Rockstroh, Mauro Schechter, Martin Markowitz, Patrick Yeni, Mona R Loutfy, Adriano Lazzarin, Jeffrey L Lennox, Kim M Strohmaier, Hong Wan, Richard JO Barnard, Bach-Yen T Nguyen, Hedy Teppler, for the BENCHMRK Study Teams

    Résumé Résumé Plan Plan   
• • ·Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

    Page :597-605

    Mark Sulkowski, Stanislas Pol, Josep Mallolas, Hugo Fainboim, Curtis Cooper, Jihad Slim, Antonio Rivero, Carmen Mak, Seth Thompson, Anita YM Howe, Larissa Wenning, Peter Sklar, Janice Wahl, Wayne Greaves, for the P05411 study investigators

    Résumé Résumé Plan Plan   
• • ·Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines

    Page :606-613

    Heidi J Larson, David MD Smith, Pauline Paterson, Melissa Cumming, Elisabeth Eckersberger, Clark C Freifeld, Isaac Ghinai, Caitlin Jarrett, Louisa Paushter, John S Brownstein, Lawrence C Madoff

    Résumé Résumé Plan Plan   
• • ·The search for an HIV cure: tackling latent infection

    Page :614-621

    Stephen J Kent, Jeanette C Reece, Janka Petravic, Alexey Martyushev, Marit Kramski, Robert De Rose, David A Cooper, Anthony D Kelleher, Sean Emery, Paul U Cameron, Sharon R Lewin, Miles P Davenport

    Résumé Résumé Plan Plan  
• • ·Frequency and implications of HIV superinfection

    Page :622-628

    Andrew D Redd, Thomas C Quinn, Aaron AR Tobian

    Résumé Résumé Plan Plan  
• • ·Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries

    Page :629-637

    Angela Loyse, Harry Thangaraj, Philippa Easterbrook, Nathan Ford, Monika Roy, Tom Chiller, Nelesh Govender, Thomas S Harrison, Tihana Bicanic

    Résumé Résumé Plan Plan
• • ·It sounds like a relapsing polychondritis

    Page :638

    Alexandre Belot, Sophie Collardeau-Frachon, Djaber Bellil, Ghislaine Descours, Yves Gillet